Sasha Latypova: COVID-19 countermeasures Evidence for an intent to harm (Jan 21, 2023)

C(ö)VID-19 countermeasures: Evidence for an intent to harm (Läkaruppropet-conference at the Stockholm Waterfront 21-22 January 2023. It gathered 15 leading doctors, researchers and lawyers from the US, Canada, UK, Germany, France, Belgium, Switzerland, Israel, Ukraine and Norway, along with 7 Swedes.) Alexandra Latypova (Sasha) holds an MBA degree and is a former Pharmaceutical R&D Executive. Sasha spent approximately 25 years in the pharmaceutical industry. She has owned and managed several contract research organisations, conducting clinical trials for over 60 pharmaceutical clients worldwide. She became concerned about the irregularities, cover-up and apparent fraud relating to the extremely high number of deaths and injuries associated with the C(ö)VID-19 ‘v(ä)ccine’ rollout.
https://lakaruppropet.se/international-conference-pandemic-strategies/